drugset / Trial / NCT00396253
A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters
NaSingle-groupOpen-labelTreatment
Summary
This was a Phase III, open-label study conducted at 44 centers in the United States, Canada, and Puerto Rico. 223 subjects who required hemodialysis (HD) and had a dysfunctional HD catheter were enrolled in the study.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenecteplase | Protein / enzyme biologic | 2 ml | Other |
| Subject | Tenecteplase | Protein / enzyme biologic | 2 mg | Other |
Indications
No indication recorded.